Research

The Melanoma group is dedicated to pioneering new treatments through basic and clinical research. Current research efforts include:

  • Novel immunotherapies
  • Oncolytic viral therapy
  • Clinical trials with vaccines
  • Regional therapy/isolated limb infusion
  • High intensity focused ultrasound
  • Examination of outcomes using large databases

Selected publications

Examining the Incidence and Presentation of Melanoma in the Cardiothoracic Transplant Population. Puza CJ, Cardones AR, Mosca PJ. JAMA Dermatol. 2018 May 1;154(5):589-591. doi: 10.1001/jamadermatol.2018.0130.

Sentinel Lymph Node Biopsy is a Prognostic Measure in Pediatric Melanoma. Kim J, Sun Z, Gulack BC, Adam MA, Mosca PJ, Rice HE, Tracy ET. J Pediatr Surg. 2016 Jun;51(6):986-90. doi: 10.1016/j.jpedsurg.2016.02.067. Epub 2016 Mar 4.

Should Patients with Stage 2 Melanoma Undergo PET-CT Staging? Lewis C. Duke Health. 2019 Feb 2. 

The Improvement Readiness Scale of the SCORE Survey: A Metric to Assess Capacity for Quality Improvement in Healthcare. Adair KC, Quow K, Frankel A, Mosca PJ, Profit J, Hadley A, Leonard M, Bryan Sexton J. BMC Health Serv Res. 2018 Dec 17;18(1):975. doi: 10.1186/s12913-018-3743-0.

Updates in Adjuvant Systemic Therapy for Melanoma. Kwak M, Farrow NE, Salama AKS, Mosca PJ, Hanks BA, Slingluff CL, Beasley GM. J Surg Oncol. 2019 Jan;119(2):222-231. doi: 10.1002/jso.25298. Epub 2018 Nov 27.

Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma. Masoud SJ, Perone JA, Farrow NE, Mosca PJ, Tyler DS, Beasley GM. Curr Treat Options Oncol. 2018 Sep 19;19(11):55. doi: 10.1007/s11864-018-0575-4.

Early-stage Melanoma and Hematopoietic Stem Cell Transplantation Outcomes. Puza CJ, Mosca PJ, Cardones AR. J Am Acad Dermatol. 2019 Mar;80(3):786-788. doi: 10.1016/j.jaad.2018.07.010. Epub 2018 Jul 17.

Outcomes of Patients with a Pretransplant History of Early-stage Melanoma. Puza CJ, Barbas AS, Mosca PJ. Melanoma Res. 2018 Oct;28(5):471-474. doi: 10.1097/CMR.0000000000000471.